7P Trastuzumab Deruxtecan (T-Dxd) for Advanced Breast Cancer (ABC) Patients (pts), Regardless of HER2 Status: A Phase II Study with Biomarkers Analysis (DAISY) - Update Analysis with Longer Follow-Up

ESMO Open(2024)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要